|
Thyroid Science An online journal dedicated to truth in thyroid science and thyroid clinical practice |
|
ABOUT US
| Home
|
Journal Staff |
Editorials & Latest Updates
| |
||
1Assistant Professor
of Endocrinology, Endocrine
Research Center
Abstract.
Introduction: This is a
prospective study of patients
treated for a solitary toxic nodule
with a fixed dose of radioiodine
(131I) and followed for at least 1
year in Mashhad, north east of Iran.
Methods: We evaluated 780
patients who presented to the
university hospital of Ghaem during
a 7-year period because they had at
least one thyroid nodule. We found
hot thyroid nodules in 95 (12%)
patients. Of these patients, 86
(90.5%) were female and 9 (9.5%)
were male. Sixty-nine (72.6%) of the
patients had thyrotoxicosis and 26
(27.4%) were euthyroid. We treated
49 thyrotoxic patients with 131I and
followed them for a minimum of 12
months. The 131I dose for all
patients was 15 mCi. The patients
underwent thyroid function testing
before treatment, at 6 months after
treatment, and, thereafter, once
every year.
Results: The single fix
dose (15 mCi) of radioiodine was
sufficient to control
hyperthyroidism in most patients
(46/49, 93.8%) in 6 months. Because
of persistent hyperthyroidism 6
months after the first dose, 3
patients (6.2%) required a second
dose.
Conclusion: A cure rate
of 93.8% can occur within 6 months
with a fixed and uncalculated dose
of radioiodine. This result is
similar to the results of treatment
with calculated dose of radioiodine.
Full
Text Free
(pdf) |